Medical publishing is a $10 billion industry whose market leaders enjoy double-digit profit margins, serving one of the fastest-growing sectors of the economy. Medical publishing has a diverse set of revenue channels. In this report, the overall market and each market segment are divided into five content delivery channels: books, journals, online content, abstracting and indexing, and other activities.
Global Medical Publishing 2021-2025 contains separate chapters covering the market, key competitors, and trends and forecast that include:
Analysis of market size and structure
Revenue and market share rankings of 10 leading global publishers
Geographic market sizing for the four major regional markets: North America, Europe, Asia-Pacific and Rest of World
Market projections to 2025 by publishing activity.
Global Medical Publishing 2021-2025 provides the intelligence to evaluate growth potential, understand trends affecting the industry, and size up the competition in the dynamic markets for STM content worldwide. Examples of some of the trends covered include:
Breakdown of publishing activities, trends and forecast
Analysis of COVID-19 impact, both immediate and long term
Key mergers and acquisitions in medical publishing
Global physician, nursing, dentistry employment
Global health expenditure forecast
U.S. import/export data for technical, scientific and professional books
The emergence of transformative agreements with libraries
Leading research funders and their links to publishers and journals
Global Medical Publishing 2021-2025 is an essential tool for publishing executives, M&A advisors, market analysts and industry consultants who need to understand the business strategies driving the medical publishing industry.
Key Topics Covered:
METHODOLOGY
DEFINITION OF MEDICAL PUBLISHING
Journals
Books
Online Content
Other Activities
Abstracting & Indexing Services
Elimination
Scope of the Report
Primary & Secondary Research
Methodology for Projecting/Estimating Results
Executive Summary
Key Facts & Trends
The Ten Largest Publishers Hold 50% of the Global Medical Market
Online Content Posts Strong Growth, Will Continue to Drive Medical Publishing Market
Medical Journals Show Stability Through COVID-19 Pandemic
North America Remains Key Market With 46% of Global Sales
World Health Care Expenditures Slowed Due to COVID-19
Continuing Medical Education and Visualization Tools Hot Properties in M&A Deals
CHAPTER 1: GLOBAL MEDICAL PUBLISHING MARKET
Market Size
Journals
Online Content
Books
Other Activities
Abstracting & Indexing (A&I) Services
Elimination
Medical Publishing by Geography
Regional Breakdown:
Language Splits and Major Publishing Hubs
North America
Europe
Asia-Pacific
Rest of the World
Currency Impact
CHAPTER 2: LEADING MEDICAL PUBLISHERS
Elsevier
Wolters Kluwer
IBM Watson Health
Springer Nature
John Wiley & Sons
Informa
Hearst Health
Athena Health
Thieme Publishing
American Medical Association
EBSCO Information Services
BMJ Publishing Group
NEJM Group
MDPI
CHAPTER 3: TRENDS & FORECAST
Current Trends in Medical Publishing
World Health Expenditure
Academic Library Trends
Renew, Transform, Cancel: Libraries Are Choosing Their Big Deal Options Very Carefully
Transformative Agreements
Average Journal Prices Increase Every Year
Leading Research Funders and Their Link to Publishing Activity
Health Care Advertising Increasingly Digital and Consumer Based
Technical, Scientific & Professional Book Export Trends
Technical, Scientific & Professional Book Import Trends
Employment Trends: Medical Doctors, Nurses & Dentists
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market. The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...
Product: Kalihim (Philippine Bread Roll)
Issue: Food - Allergen - Egg
Distribution: British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform.
Panda Health...